PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 20240 citations

Table S2 from Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity

View Full Paper
AGAndrew A. GuirguisYOYaara Ofir-RosenfeldKKKathy Knezevic

Key Points

Key points are not available for this paper at this time.

Abstract

Flow antibodies

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Guirguis et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523e9fhttps://doi.org/10.1158/2159-8290.27026021.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Table S3 from Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity2024
  2. 2Table S3 from Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity2024
  3. 3Table S3 from Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity2024
  4. 4Table S3 from Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity2024
  5. 5Figure S1 from Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity2024